Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Leniolisib in children aged 1 to 6 years with APDS
jRCT2031230417Active, not recruiting
- Sponsor
- Pharming Group
- Start
- Nov 2023
- Modality
- Small Molecules
01
Overview
Open-label, single-arm trial of leniolisib in Activated PI3Kδ syndrome (APDS), sponsored by Pharming Group. Started Nov 2023; status: active, not recruiting.
02
Drugs
leniolisib
03
Conditions
Activated PI3Kδ syndrome (APDS)
Beyond the preview
Go deeper on jRCT2031230417.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2031230417.